In murine models, low to moderate cardiac-specific overexpression of Sirt1 has been shown to effectively alleviate age-related progression of cardiac hypertrophy, fibrosis, apoptosis, and decline in cardiac function (Alcendor et al. 2007). The gene discussed is SIRT1; the disease is cardiac hypertrophy.